Paul Govern

April 21, 2022

When science spills onto social media

Vanderbilt researchers report that social media posts can offer insights into how the public feels about genome editing, with stances varying across platforms and differing from those of academics and policy makers.

By Paul Govern
April 21, 2022

Kalousová, Bolton receive Alzheimer’s Association awards

Vanderbilt’s Lucie Kalousová, PhD, and Corey Bolton, PsyD, have received research awards from the Alzheimer’s Association.

By Paul Govern
April 7, 2022

Computer eyeballs graft-vs-host disease

A machine learning algorithm identified areas of skin affected by chronic graft-versus-host disease on par with clinicians, opening the door to streamlining and standardizing this measure of patient response to therapy.

By Paul Govern
Leon Cai explains his poster to Sharon Kam (center) and Katherine Lee at the 2022 Alzheimer’s Disease Research Day.
April 7, 2022

Event highlights research on Alzheimer’s disease

The third annual Vanderbilt Alzheimer’s Disease Research Day featured numerous presentations and concluded with a keynote address by Suzanne Craft, PhD, director of the Alzheimer’s Disease Research Center at Wake Forest University.

By Paul Govern
March 29, 2022

There’s no slowing arterial stiffening

Over 10 years, multiple healthy behaviors did not slow the progression of arterial stiffness, a risk factor for coronary artery disease, hypertension, stroke, atrial fibrillation and heart failure.

By Paul Govern
Inga Saknite, PhD, Eric Tkaczyk, MD, PhD, and colleagues are studying how white blood cell motion in the skin’s microvasculature can help predict which stem cell and bone marrow transplant patients would have a relapse of their blood cancer. (photo by Anne Rayner)
March 28, 2022

Study finds 10-second videos predict blood cancer relapse

Vanderbilt research shows that 10-second videos of white blood cell motion in the skin’s microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would have a relapse of their blood cancer.

By Paul Govern
March 24, 2022

VUMC Clickbusters program helps reduce EHR alerts

Vanderbilt's Clickbusters program is helping to stem alert fatigue associated with the Medical Center's clinical IT system.
By Paul Govern
March 17, 2022

U.S. precision medicine research program releases genomic data

The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants.
By Paul Govern
March 17, 2022

Blood test figures in cancer risk for people with HIV

A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer.
By Paul Govern
March 17, 2022

Talbot named to infection prevention society’s leadership

Vanderbilt's Tom Talbot, MD, MPH, was recently elected to serve in the leadership of the Society for Healthcare Epidemiology of America.
By Paul Govern
March 16, 2022

Mangeot named VUMC chief compliance officer

Bob Mangeot has been promoted to Vice President and Chief Compliance Officer at Vanderbilt University Medical Center, having served in the role on an interim basis since December.
By Paul Govern
March 3, 2022

Chatbot takes first prize in Mental Health Innovation challenge

A chatbot — a computer program that simulates and processes human conversation — was the winning entrant in Vanderbilt's recent Mental Health Innovation Challenge and Hackathon.
By Paul Govern
1 … 12 13 14 15 16 … 52